Conjugated estrogens: FDA's position.
Burlington
D B
DB
Office of Generic Drugs, Food and Drug Administration.
D004966:Estrogens, Conjugated (USP) / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration
D004966:Estrogens, Conjugated (USP)